scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study

01 Dec 2018-Atherosclerosis (Atherosclerosis)-Vol. 279, pp 52-61
TL;DR: The effects of a diet with less than 20 g carbohydrates per day (LCHF) on plasma low density lipoprotein cholesterol (LDL-C) in young and healthy adults and the assessment of lipid profile and peripheral blood mononuclear cells (PBMC) gene expression are explored.
About: This article is published in Atherosclerosis.The article was published on 2018-12-01 and is currently open access. It has received 62 citations till now. The article focuses on the topics: Atkins diet.

Summary (4 min read)

1. Introduction

  • The role of low carbohydrate high fat (LCHF) diets in relation to health effects is debated in the scientific literature [1, 2] as well as the role of saturated fatty acids for the development of atherosclerosis despite the overwhelming evidence linking saturated fat to increased LDL-C level [3-5].
  • Butter and cream are typically promoted as healthy in LCHF literature, and in Norway, the use of butter increased by 24% during the period 2009-2012 [13].
  • Indeed, LCHF diets are used not only by overweight, but by healthy normal-weight people as well [27].

Study participants

  • Participants were mostly recruited among students or employees at the Department of Nutrition Research at the University of Oslo after information meetings.
  • The participants were included if they were willing to change their dietary intake according to the restrictions in a LCHF diet, provided informed consent and if they fulfilled the inclusion criteria after a physical examination by the study physician.
  • Inclusion criteria were age 18 years or older, no chronic disease present, alcohol consumption less than 14 units per week and not following any particular dietary restrictions.
  • Exclusion criteria were chronic diseases, regular use of medications (except oral contraceptives), blood pressure ≥140/90 mm Hg, pregnant or lactating women.

Study design and diet

  • The study was a three week randomized controlled parallel-designed intervention study, performed in the period September 2011 to December 2012.
  • The diet was self-selected, thus the type of fat was optional.
  • A partial limited intake existed for some food items such as whole-fat cheeses containing carbohydrates and vegetables with low carbohydrate content, such as spinach, sprouts, mushrooms, cucumber and avocado.
  • The study was registered in ClinicalTrials.gov with the ID number: NCT01476436.
  • A weighed dietary record was also performed for three days during the LCHF diet period.

Anthropometric measures

  • Body weight, fat free mass, fat mass and total body water were determined using a bioimpedance analyzer (Tanita TBF-300, Tanita Corp., Japan) at baseline and after three weeks of LCHF diet.
  • The measurement was undertaken according to the manual and the subjects fasted for at least eight hours prior to study visits.
  • During the measurement the subjects were in standing position with the arms and legs abducted from the body and instructed not to move or speak.

Blood pressure

  • Fasting systolic and diastolic blood pressure (BP) measurements were performed by trained personnel.
  • Three measurements at 1-minute intervals were recorded after 10 minutes of rest in a waiting room followed by another 5 minutes in an investigation room where the subject sat in a resting chair with the cuff mounted and the arm at the armrest.
  • Validated oscillometric devices (Carescape V100, GE Healthcare, Norway) with suitable cuffs were used for the measurements.
  • In the analyses the authors used the mean of all three measurements.

Routine laboratory analysis

  • Fasting blood samples were drawn at baseline and after three weeks.
  • Plasma was obtained from EDTA tubes (Becton Dickinson), immediately placed on ice and centrifuged within 10 minutes (1500 rpm, 4°C, 15 minutes).
  • Plasma (P)-TC and P-triglyceride (TG) was measured with an enzymatic colorimetric assay, while P-LDL-C and P-high density lipoprotein cholesterol (HDL-C) was measured with a homogeneous enzymatic colorimetric assay.
  • Four hundred ng of RNA from all samples was reverse transcribed using High capacity RNA-to-cDNA kit (Applied Biosystems, Foster City, CA).
  • Ct values of the two reference genes (=ΔCt).

Statistical analyses

  • Data are presented as mean ± standard deviation (SD) if normally distributed, or median (minimum-maximum) if not normally distributed.
  • Wilcoxon signed rank test was used to assess change within groups and Mann Whitney U test was used to compare changes between groups when the data was not normally distributed.
  • IBM SPSS Statistics v 20 (Armonk, NY, USA) was used for statistical analysis.
  • In the present study the authors used a conservative approach and hypothesized that Atkins diet would lead to an increase in LDL-C from 2.0 to 2.5 mmol/l, which is a less increase than what they observed in a small pilot study [33].
  • With 80% power and a level of significance of 0.05 and a SD of 0.5 mmol for LDL-C the necessary sample size (for each sample separately) was 16.

3. Results

  • Forty-one subjects met to the screening visit and two did not fulfill the inclusion criteria.
  • Table 1 shows the baseline and end of study characteristics of the participants.
  • The routine laboratory measurements for lipids, glucose and CRP were within the reference value in all participants at baseline (Table 1).
  • During the study period, weight and BMI was significantly reduced in both the LCHF and the control group (1.2 kg and 2.0 kg and 0.4 kg/m2 and 0.7 kg/m2, respectively).

Dietary intake and compliance

  • A total of 18 participants performed a weighed dietary record of their habitual diet and 10 participants performed a weighed dietary record of their LCHF diet (Table 2).
  • The E% from total fat, saturated fat, monounsaturated fat, polyunsaturated fat, protein, carbohydrate and dietary cholesterol differed significantly between the habitual diet and the LCHF diet (all p<0.001).
  • Expression of LDL receptor and other lipid-related genes and circulating PCSK9 level.
  • One of the suggested mechanisms by which saturated fat increase LDL-C levels is through modulation of the LDL receptor.
  • The gene expression of the transcription factor SREBP-1 were significantly different between the LCHF and control group after three weeks (p=0.01) (Table 4), whereas there were no significant difference between the groups in the change of the expression of the other lipidrelated genes.

Adverse events

  • There were two serious adverse events during the study, both occurred in the LCHF group.
  • One healthy participant experienced chest pain three days after starting on the LCHF diet.
  • ST-elevation was observed at the electro cardiogram at admission to hospital and severely elevated serum levels of Troponins and Creatine kinase-MB were observed.
  • The patient was excluded from the study and partly recovered after standard medical treatment and restarting eating carbohydrate.

4. Discussion

  • An important finding of this study is, that after three weeks on a LCHF diet, mean plasma LDL-C increased by 44% compared to the control group.
  • An interesting finding in the present study was the striking differences between individuals in the response to a LCHF diet, in particular for plasma levels of LDL-C.
  • In the present study, the authors observed a 30%, but not statistically significant decrease, in LDL receptor gene expression in the LCHF group.
  • Other study limitations are the small study population albeit the p-values on primary end points were strong.
  • The metabolic stress caused by this diet may be used as a model for research on the regulation of LDL-C levels in human since little is known about the molecular mechanisms behind the large individual differences.

Conflict of interest

  • K.R. has received grants or honoraria for meeting and lectures the last three years from Amgen, Chiesi, Sanofi, Mills DA, MSD , Oslo Economics, Takeda outside the submitted work and has received honoraria for participation in meetings for Norwegian Directorate of Health and the Norwegian Medical Association outside the submitted work.
  • K.B.H has received grants from TINE SA, Mills DA, Olympic Seafood, Amgen, Sanofi, Kaneka, and Pronova outside the submitted work.

Financial support

  • The authors thank The Mills Vita Heart Foundation, The Throne Holst Foundation, Aktieselskabet Freia Chocolade Fabriks Medisinske Fond, Norsk Fond for Klinisk Kjemi, Dr. Fürst medisinske laboratoriums fond til klinisk kjemisk og klinisk fysiologisk forskning for financial support to this study.
  • The funding bodies had no role in the conduct of the research and/or preparation of the article, study design, collection, analysis or interpretation of data, neither in the writing of the report; or in the decision to submit the article for publication.

Author contributions

  • K.B.H., M.S. and K.R conceived of the idea and planned the experiments.
  • K.R. conducted the clinical part of the study, K.B.H. conducted the biochemical and genetic analysis and was responsible for the statistical work, I.N. conducted the genetic analysis and M.S conducted the nutritional measurement and.
  • All authors did statistical work, discussed and interpreted the results and made substantial contributions to the final manuscript.

Figure Legends

  • R denotes randomization, Habitual diet denotes the control arm, LCHF diet denotes low carbohydrate high fat diet.
  • Each bar represent one subject’s percent change in plasma lipids, as indicated by the text in each panel A-F.
  • The fasting plasma levels at baseline were compared to fasting plasma levels after using LCHF for 3 weeks expressed as percent change.
  • Subjects were ranked in order after the percent increase in LDL-C, from least change to the left side in the panel and the largest change to the right side of the panel.
  • Panel A: LDL-C; Low density lipoprotein cholesterol, Panel B: TC; Total cholesterol, Panel C: HDL-C;.

Did you find this useful? Give us your feedback

Citations
More filters
Journal ArticleDOI
TL;DR: Based on the evidence reviewed, low-CHO and very-low-CHO diets are not superior to other dietary approaches for weight loss and may have advantages related to appetite control, triglyceride reduction, and reduction in the use of medication in T2D management.

204 citations


Cites background from "Effect of low carbohydrate high fat..."

  • ...%) in the other RCT.85 In their narrative review on nutrigenetics and blood cholesterol levels, VazquezVidal et al. reviewed gene-nutrient interaction studies that examined inter-individual variability in blood cholesterol responses.86 Some studies have shown significant associations between the APOE4 allele and an increased LDL-C response to dietary interventions while others found no association indicating the LDL-C response varies based on different types of dietary interventions (ie, amount and type of fat and cholesterol) or specific foods.86,87 Thus, it is essential to assess the lipid profile of patients who choose to follow low-CHO or very-low-CHO diets and KDs....

    [...]

  • ...Due to the unpredictable response of LDL-C to VLCHF/KDs, all patients who choose to follow these diets should have baseline and follow-up lipoprotein lipid profiles assessed.(85) Some patients with severe hypertriglyceridemia may have genetic or acquired causes of lipoprotein lipase dysfunction or deficiency, with predisposition to hyperchylomicronemia and acute pancreatitis....

    [...]

  • ...The increase in LDL-C ranged between 5–10% in one RCT(84) and 44% (range 5% to 107%) in the other RCT.(85) In their narrative review on nutrigenetics and blood cholesterol levels, VazquezVidal et al....

    [...]

Journal ArticleDOI
Rachel Freire1
TL;DR: There is no one most effective diet to promote weight loss and adherence to diets will predict their success, so it is fundamental to adopt a diet that creates a negative energy balance and focuses on good food quality to promote health.

133 citations


Cites background from "Effect of low carbohydrate high fat..."

  • ...Moreover, HP-HF diets are often associated with a high intake of animal products and saturated fat, causing detrimental effects of increased low-density lipoprotein cholesterol [39,40]....

    [...]

Journal ArticleDOI
TL;DR: The debate reproduced in this article took place during a continuous medical education program between two cardiologists with largely differing views on the matter of effectiveness, sustainability, and safety of the ketogenic diet compared to alternative options.

102 citations

Journal ArticleDOI
TL;DR: The ketogenic diet has recently received much attention for its promise of treating obesity and type 2 diabetes, but there is little if any evidence that ketogenic diets specifically improve carbohydrate intolerance independent of weight loss, unlike other dietary approaches in which glycemic control is improved despite the consumption of healthful carbohydrate-rich foods, such as legumes, whole grains, and fruits.
Abstract: The ketogenic diet has recently received much attention for its promise of treating obesity and type 2 diabetes. However, the enthusiasm for its potential benefits exceeds the current evidence supporting its use for these conditions. Although the temptation is great to recommend a potentially novel approach for otherwise difficult-to-treat diseases, it is important to remain grounded in our appraisal of the risks, benefits, and applicability of the diet to avoid unnecessary harm and costs to patients. The ketogenic diet, or keto diet, emerged in popularity after a recent series of other low-carbohydrate diets, such as the Paleo and Atkins diets. The ketogenic diet is unique from other low-carbohydrate diets in that followers of the diet are encouraged to forgo nearly all carbohydrates, avoid excess protein, and consume high levels of fat (generally exceeding 70% of calories consumed), resulting in the production of ketones, giving the diet its name. The excitement for low-carbohydrate diets comes on the heels of what some have considered the failure of a low-fat diet to curb the obesity epidemic and its associated increase in type 2 diabetes. This enthusiasm is belied by the fact that the modern American diet is not truly low in fat (defined as less than 30% of total calories). Of more importance, from the early 1970s to the early 2000s, Americans increased total energy consumption by at least 240 calories per day (estimates vary by method and source), likely contributing to weight gain and the increased incidence of diabetes. Is the ketogenic diet more effective for weight loss than other diets? In a meta-analysis of 13 studies lasting longer than a year, researchers found that the ketogenic diet was associated with less than a kilogram of additional weight loss over high-carbohydrate, low-fat strategies.1 This difference, although statistically significant, may not be clinically significant. Furthermore, a meta-analysis of 32 controlled feeding studies found that energy expenditure and fat loss were greater with low-fat diets compared with ketogenic diets.2 Any diet that results in weight loss does so because it reduces calorie intake. The ketogenic diet, when used for weight loss, is no different. The salient questions are whether it is sustainable and whether it promotes long-term health. No studies, to our knowledge, have evaluated ketogenic diets for cardiovascular events or mortality, although observational studies in the broader low-carbohydrate diet literature suggest increased all-cause mortality.3 What about the role of a ketogenic diet in the treatment of type 2 diabetes? One well-publicized, nonrandomized study of the ketogenic diet in persons with type 2 diabetes showed a 1.3% reduction in glycosylated hemoglobin at 1 year in the ketogenic group.4 These findings must be interpreted with caution, however, because the ketosis group was self-selected and received intensive technological and behavioral support not offered to the control group. Long-term ( 1 year) randomized studies tell a different story. A meta-analysis of randomized long-term studies comparing the ketogenic diet with low-fat diets for weight loss reported no difference in glycemic control among persons with type 2 diabetes.1 Type 2 diabetes is characterized by carbohydrate intolerance due to insulin resistance. Restriction of carbohydrates (as in the ketogenic diet) can transiently improve glycemic control, and weight loss by any means can improve insulin resistance. However, there is little if any evidence that ketogenic diets specifically improve carbohydrate intolerance independent of weight loss, unlike other dietary approaches in which glycemic control is improved despite the consumption of healthful carbohydrate-rich foods, such as legumes, whole grains, and fruits, even in the absence of weight loss. Are there other possible benefits of a ketogenic diet? The ketogenic diet has been touted to have favorable effects on cardiovascular risk factors, such as serum lipid levels. However, evidence suggests that low-density lipoprotein cholesterol and apo-B–containing lipoprotein levels may fail to improve, or even significantly increase, with a ketogenic diet despite weight loss.5 Although there may be a concurrent increase in highdensity lipoprotein cholesterol level with a ketogenic diet, historically, various interventions used to increase high-density lipoprotein cholesterol level have not translated into reductions in cardiovascular events. In terms of the risk-benefit balance of the ketogenic diet, the potential adverse effects may give one pause. A review of the literature6,7 on ketogenic diets for the treatment of pediatric epilepsy reveals multiple adverse effects, ranging from the relatively benign but inconvenient “keto flu,” an induction period of fatigue, weakness, and gastrointestinal disturbances, to the less common but deadlier occurrence of cardiac arrhythmias from selenium deficiency. Other documented adverse effects include nephrolithiasis, constipation, halitosis, muscle cramps, headaches, diarrhea, restricted growth, bone fractures, pancreatitis, and multiple vitamin and mineral deficiencies. The greatest risk, however, of the ketogenic diet may be the one most overlooked: the opportunity cost of not eating high-fiber, unrefined carbohydrates. Whole grains, fruits,andlegumesaresomeofthemosthealth-promoting foods on the planet. They are not responsible for the epidemics of type 2 diabetes or obesity, and their avoidance VIEWPOINT

82 citations

Journal ArticleDOI
17 Feb 2021
TL;DR: In this paper, the authors compared the effects of intermittent calorie restriction (the 5:2 diet) and a low-carb high-fat diet (LCHF) on reduction of hepatic steatosis.
Abstract: Background & Aims The first-line treatment for non-alcoholic fatty liver disease (NAFLD) is weight reduction. Several diets have been proposed, with various effects specifically on liver steatosis. This trial compared the effects of intermittent calorie restriction (the 5:2 diet) and a low-carb high-fat diet (LCHF) on reduction of hepatic steatosis. Methods We conducted an open-label randomised controlled trial that included 74 patients with NAFLD randomised in a 1:1:1 ratio to 12 weeks' treatment with either a LCHF or 5:2 diet, or general lifestyle advice from a hepatologist (standard of care; SoC). The primary outcome was reduction of hepatic steatosis as measured by magnetic resonance spectroscopy. Secondary outcomes included transient elastography, insulin resistance, blood lipids, and anthropometrics. Results The LCHF and 5:2 diets were both superior to SoC treatment in reducing steatosis (absolute reduction: LCHF: −7.2% [95% CI = −9.3 to −5.1], 5:2: −6.1% [95% CI = −8.1 to −4.2], SoC: −3.6% [95% CI = −5.8 to −1.5]) and body weight (LCHF: −7.3 kg [95% CI = −9.6 to −5.0]; 5:2: −7.4 kg [95% CI = −8.7 to −6.0]; SoC: −2.5 kg [95% CI =−3.5 to −1.5]. There was no difference between 5:2 and LCHF (p = 0.41 for steatosis and 0.78 for weight). Liver stiffness improved in the 5:2 and SoC but not in the LCHF group. The 5:2 diet was associated with reduced LDL levels and was tolerated to a higher degree than LCHF. Conclusions The LCHF and 5:2 diets were more effective in reducing steatosis and body weight in patients with NAFLD than SoC, suggesting dietary advice can be tailored to meet individual preferences. Lay summary For a person with obesity who suffers from fatty liver, weight loss through diet can be an effective treatment to improve the condition of the liver. Many popular diets that are recommended for weight reduction, such as high-fat diets and diets based on intermittent fasting, have not had their effects on the liver directly evaluated. This study shows that both a low-carb high-fat and the 5:2 diet are effective in treating fatty liver caused by obesity. Clinical Trials Registration This study is registered at Clinicaltrials.gov (NCT03118310).

58 citations

References
More filters
Journal ArticleDOI
01 Dec 2001-Methods
TL;DR: The 2-Delta Delta C(T) method as mentioned in this paper was proposed to analyze the relative changes in gene expression from real-time quantitative PCR experiments, and it has been shown to be useful in the analysis of realtime, quantitative PCR data.

139,407 citations

Journal ArticleDOI
TL;DR: Two mutations in the gene PCSK9 (encoding proprotein convertase subtilisin/kexin type 9) that cause ADH are reported, a newly identified human subtilase that is highly expressed in the liver and contributes to cholesterol homeostasis.
Abstract: Autosomal dominant hypercholesterolemia (ADH; OMIM144400), a risk factor for coronary heart disease, is characterized by an increase in low-density lipoprotein cholesterol levels that is associated with mutations in the genes LDLR (encoding low-density lipoprotein receptor) or APOB (encoding apolipoprotein B). We mapped a third locus associated with ADH, HCHOLA3 at 1p32, and now report two mutations in the gene PCSK9 (encoding proprotein convertase subtilisin/kexin type 9) that cause ADH. PCSK9 encodes NARC-1 (neural apoptosis regulated convertase), a newly identified human subtilase that is highly expressed in the liver and contributes to cholesterol homeostasis.

2,691 citations


"Effect of low carbohydrate high fat..." refers background in this paper

  • ...Together with proprotein convertase subtilisin/kexin type 9 (PCSK9), which modulates the degradation of LDL receptors [30], these factors are key regulators of the serum LDL-C levels....

    [...]

Journal ArticleDOI
TL;DR: Consistent evidence from numerous and multiple different types of clinical and genetic studies unequivocally establishes that LDL causes ASCVD.
Abstract: Aims To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs) cause atherosclerotic cardiovascular disease (ASCVD).

2,003 citations

Journal ArticleDOI
TL;DR: In this article, the authors randomly assigned 322 moderately obese subjects (mean age, 52 years; mean body-mass index [the weight in kilograms divided by the square of the height in meters], 31; male sex, 86%) to one of three diets: low-fat, restricted-calorie; Mediterranean, restricted calorie; or low-carbohydrate, non-restricted calorie.
Abstract: Background Trials comparing the effectiveness and safety of weight-loss diets are frequently limited by short follow-up times and high dropout rates. Methods In this 2-year trial, we randomly assigned 322 moderately obese subjects (mean age, 52 years; mean body-mass index [the weight in kilograms divided by the square of the height in meters], 31; male sex, 86%) to one of three diets: low-fat, restricted-calorie; Mediterranean, restricted-calorie; or low-carbohydrate, non–restricted-calorie.

1,691 citations

Journal ArticleDOI
TL;DR: Dariush Mozaffarian and colleagues conduct a systematic review and meta-analysis to investigate the effect of consuming polyunsaturated fats in place of saturated fats for lowering the risk of coronary heart disease.
Abstract: Background: Reduced saturated fat (SFA) consumption is recommended to reduce coronary heart disease (CHD), but there is an absence of strong supporting evidence from randomized controlled trials (RCTs) of clinical CHD events and few guidelines focus on any specific replacement nutrient. Additionally, some public health groups recommend lowering or limiting polyunsaturated fat (PUFA) consumption, a major potential replacement for SFA. Methods and Findings: We systematically investigated and quantified the effects of increased PUFA consumption, as a replacement for SFA, on CHD endpoints in RCTs. RCTs were identified by systematic searches of multiple online databases through June 2009, grey literature sources, hand-searching related articles and citations, and direct contacts with experts to identify potentially unpublished trials. Studies were included if they randomized participants to increased PUFA for at least 1 year without major concomitant interventions, had an appropriate control group, and reported incidence of CHD (myocardial infarction and/or cardiac death). Inclusions/exclusions were adjudicated and data were extracted independently and in duplicate by two investigators and included population characteristics, control and intervention diets, follow-up duration, types of events, risk ratios, and SEs. Pooled effects were calculated using inverse-variance-weighted random effects meta-analysis. From 346 identified abstracts, eight trials met inclusion criteria, totaling 13,614 participants with 1,042 CHD events. Average weighted PUFA consumption was 14.9% energy (range 8.0%–20.7%) in intervention groups versus 5.0% energy (range 4.0%–6.4%) in controls. The overall pooled risk reduction was 19% (RR=0.81, 95% confidence interval [CI] 0.70–0.95, p=0.008), corresponding to 10% reduced CHD risk (RR=0.90, 95% CI=0.83–0.97) for each 5% energy of increased PUFA, without evidence for statistical heterogeneity (Q-statistic p=0.13; I 2 =37%). Meta-regression identified study duration as an independent determinant of risk reduction (p=0.017), with studies of longer duration showing greater benefits. Conclusions: These findings provide evidence that consuming PUFA in place of SFA reduces CHD events in RCTs. This suggests that rather than trying to lower PUFA consumption, a shift toward greater population PUFA consumption in place of SFA would significantly reduce rates of CHD. Please see later in the article for the Editors’ Summary.

1,049 citations


"Effect of low carbohydrate high fat..." refers background in this paper

  • ...Several large association studies have, however, challenged the view that saturated fat increases the risk for CVD [15–17], while other studies find clear correlation with intake of SFA and risk of CVD [18,19]....

    [...]

  • ...There are no randomized controlled trials (RCT's) reporting outcomes on hard end points, such as CVD, after the use of LCHF diets....

    [...]

  • ...T (CVD)....

    [...]

Related Papers (5)
Frequently Asked Questions (16)
Q1. What was used to assess change between groups when the data was not normally distributed?

Wilcoxon signed rank test was used to assess change within groups and Mann Whitney U test was used to compare changes between groups when the data was not normally distributed. 

The role of low carbohydrate high fat ( LCHF ) diets in relation to health effects is debated in the scientific literature this paper. 

Taken together, further research is needed on how this class of drugs affects lipid metabolism. In clinical practice, the unpredictable response to the LCHF diet suggests that LDL-C should be measured in people using a LCHF diet. 

Less than 20 grams carbohydrates per day are allowed in the initially phase of the Atkin diet, typically resulting in a high intake of saturated fat. 

During the measurement the subjects were in standing position with the arms and legs abducted from the body and instructed not to move or speak. 

Population surveys in Norway have reported that 29% of adult women and 21% of men had been on a “low carbohydrate diet” the last 12 months [27]. 

Due to diet restrictions on carbohydrates, beer, wine and liquor containing carbohydrate alcohol was naturally limited in the LCHF group but there were no restriction on alcohol intake as such. 

In a study of more than 32,000 U.S. dieters, nearly 34% of respondents reported that the Atkins diet helped them to loose and maintain weight [10]. 

Together with proprotein convertase subtilisin/kexin type 9 (PCSK9), which modulate the degradation of LDL receptors [30], these factors are key regulators of the serum LDL-C level. 

It is important to gain knowledge of how LCHF diet influence cardiovascular risk factors in normal-weight subjects since the use of LCHF diets is popular and not restricted to weight reduction in obesity only. 

Another meta-analysis of eleven RCT’s with 1369 participants using a diet with less than 20 E% carbohydrate also observed an increase in LDL-C (0.16 mmol/l, 95% CI: 0.003, 0.33) [22]. 

In the present study the authors used a conservative approach and hypothesized that Atkins diet would lead to an increase in LDL-C from 2.0 to 2.5 mmol/l, which is a less increase than what the authors observed in a small pilot study [33]. 

The participants were included if they were willing to change their dietary intake according to the restrictions in a LCHF diet, provided informed consent and if they fulfilled the inclusion criteria after a physical examination by the study physician. 

A meta-analysis on the effect of low carbohydrate diets with 23 RCT`s reported a statistically significant higher LDL-C (0.1 mmol/l, 95% CI: 0.026- 0.165) in the low-carbohydrate versus the low-fat diet groups [21]. 

All analyzes were accredited after International and European standard NS-EN ISO 15189Expression of lipid-related genes in peripheral blood mononuclear cells (PBMCs)After blood collection, PBMCs were isolated by using the BD Vacutainer CellPreparation tubes with sodium heparin according to the manufacturer (Becton Dickinson, San Jose, CA) and stored as pellets at -80o C until further mRNA isolation. 

RNA quantity and quality measurements were performedusing ND 1000 Spectrophotometer (Saveen Werner Carlson Circle Tampa, FL) and Agilent Bioanalyser (Agilent Technology, Santa Clara, CA), respectively. 

Trending Questions (1)
Does a high carbohydrate and high fat diet affect the VLDL and LDL levels?

The provided paper does not mention the effects of a high carbohydrate and high fat diet on VLDL and LDL levels.